1. Baltzer V, Schmutz M (1978) Experimental anticonvulsive properties of GP 47 680 and of GP 47 779, its main human metabolite; compounds related to carbamazepine.In: Meinardi H, Rowan AJ (eds) Advances in Epileptology. Lisse: Swets and Zeitlinger, Amsterdam, pp. 295–299
2. Bartoszyk GD (1983) Gabapentin and convulsions provoked by excitatory amino acids. Naunyn-Schmiedeberg’s Arch Pharmacol 324:R24
3. Bartoszyk GD, Hamer M (1987) The genetic animal model of reflex epilepsy in the Mongolian gerbil: differential efficacy of new anticonvulsive drugs and prototype antiepileptics. Pharmacol Res Commun 19:429–440
4. Bartoszyk GD, Reimann W (1985) Preclinical characterization of the anticonvulsant gabapentin. 16th Epilepsy International Congress, Hamburg
5. Bartoszyk GD, Meyerson N, Reimann W, Satzinger G, von Hodenberg A (1986) Gabapentin. In: Meldrum BS, Porter RJ (eds) Current problems in epilepsy: new anticonvulsant drugs. John Libbey & Company, London, pp. 147–164